Attract talent




ESCAPE Bio is a preclinical stage biopharmaceutical company focused on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. We are passionate about making a meaningful clinical impact for patients suffering from CNS diseases and believe in a genetically defined approach to achieving this goal


Add photos to showcase ESCAPE Bio’s culture


Add ESCAPE Bio’s values

Insider experiences

Share your experience of working at ESCAPE Bio

Julie Anne Smith
President & Chief Executive Officer
Anthony M. Rimac
Chief Financial Officer
Carrolee Barlow
Chief Medical Officer
Paul Wren
Chief Scientific Officer
Brian Edquist
Vice President – R&D Operations
Nick France
Vice President, Clinical Research
Mari Maurer
VP, Clinical Operations
Holly Carlisle
Head of Biology
Jacob B. Schwarz
Head of Chemistry

Add your teams to show how people work together at ESCAPE Bio

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.